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Mitochondrial dysfunction plays a pivotal role in the progression of Alzheimer’s disease
(AD), and yet the mechanisms underlying the impairment of mitochondrial function in
AD remain elusive. Recent evidence suggested a role for Presenilins (PS1 or PS2)
in mitochondrial function. Mutations of PSs, the catalytic subunits of the γ-secretase
complex, are responsible for the majority of inherited AD cases (FAD). PSs were shown
to be present in mitochondria and particularly enriched in mitochondria-associated
membranes (MAM), where PS2 is involved in the calcium shuttling between mitochondria
and the endoplasmic reticulum (ER). We investigated the precise contribution of PS1
and PS2 to the bioenergetics of the cell and to mitochondrial morphology in cell
lines derived from wild type (PS+/+), PS1/2 double knock-out (PSdKO), PS2KO
and PS1KO embryos. Our results showed a significant impairment in the respiratory
capacity of PSdKO and PS2KO cells with reduction of basal oxygen consumption,
oxygen utilization dedicated to ATP production and spare respiratory capacity. In line
with these functional defects, we found a decrease in the expression of subunits
responsible for mitochondrial oxidative phosphorylation (OXPHOS) associated with
an altered morphology of the mitochondrial cristae. This OXPHOS disruption was
accompanied by a reduction of the NAD+/NADH ratio. Still, neither ADP/ATP ratio nor
mitochondrial membrane potential (19) were affected, suggesting the existence of a
compensatory mechanism for energetic balance. We observed indeed an increase in
glycolytic flux in PSdKO and PS2KO cells. All these effects were truly dependent on PS2
since its stable re-expression in a PS2KO background led to a complete restoration
of the parameters impaired in the absence of PS2. Our data clearly demonstrate
here the crucial role of PS2 in mitochondrial function and cellular bioenergetics,
pointing toward its peculiar role in the formation and integrity of the electron transport
chain.
Keywords: presenilin, mitochondria, glycolysis, oxidative phosphorylation, cellular bioenergetics, Alzheimer’s
disease
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INTRODUCTION
Metabolic dysfunction is central in Alzheimer’s disease (AD)
since it appears at very early stage of the disorder, even before
clinical symptoms (Chen and Zhong, 2013). It is evidenced in
patients by a decrease in glucose utilization in temporoparietal
association areas, together with cognitive decline and a severe
failure in mitochondria oxidative metabolism (Herholz, 2012).
Mitochondria are known as the powerhouse of the cell for
their capacity to supply energy, but they are also critical in
other cellular processes such as apoptosis, reactive oxygen
species (ROS) production (Paradies et al., 2014), and calcium
homeostasis (Osellame et al., 2012). All these processes turn
out to be affected in AD pathology (Hroudova et al., 2014).
Studies carried out either on AD patients’ tissue samples or
AD transgenic mice models reported an array of mitochondrial
dysfunctions, including a morphological shift toward fission
(Wang et al., 2009), a disrupted motility (Wang et al., 2009; Xie
et al., 2013), an impairment of the electron transport chain (ETC)
(Bosetti et al., 2002), and an increase in ROS production with
deleterious effects on mitochondrial DNA integrity (Onyango
et al., 2006). In cytoplasmic hybrid (cybrid) cell lines, generated
by insertion of platelets’ mitochondria collected from sporadic
AD (SAD) patients into human neuroblastoma cells (SHSY5Y)
depleted of mitochondria, bioenergetics dysfunctions such as
oxidative phosphorylation (OXPHOS) and glucose utilization
defects have been observed (Silva et al., 2013). These metabolic
perturbations found in AD raised a chicken and the egg issue,
namely to define whether mitochondrial dysfunction is a cause
or a consequence in this pathology.
Recent studies suggested that Presenilins are involved in the
control of mitochondrial functions (Behbahani et al., 2006; Filadi
et al., 2016). PS1 and PS2 are two homologous polytopic aspartyl
proteases identified as the catalytic subunits of the γ-secretase
complex. PSs are directly involved in AD since the production
of Aβ is generated after the sequential cleavage of the Amyloid
Precursor Protein (APP) by the β and the γ-secretase (Zheng
and Koo, 2011). Aβ is the major component of senile plaques
found in the brain of AD patients (Miller et al., 1993). Beside their
key role in γ-secretase activity and Aβ production, mounting
evidence indicate additional roles for PSs in cell physiology, for
which their catalytic activity seems less evident. PSs are involved
in calcium homeostasis (Zhang et al., 2013), autophagy (Lee et al.,
2010), neurotransmitters release (Zhang et al., 2009), synaptic
plasticity and memory (Saura et al., 2004). Moreover, although
PSs have different localization in the cell with PS1 mainly located
at the plasma membrane and PS2 in the trans-Golgi network and
Abbreviations: 19 , mitochondrial membrane potential; 1R1, PS1 knockout
rescued PS1; 2R2, PS2 knockout rescued PS2; AD, Alzheimer disease; APP, amyloid
precursor protein; CI-CV, complexes I-V; DTAB, dodecyltrimethylammonium
bromide; ETC, electron transport chain; ER, endoplasmic reticulum; FAD,
familial AD; FC, flow cytometry; FCCP, carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone; HPLC, high pressure liquid chromatography; MAM,
mitochondria-associated membranes; MEF, mouse embryonic fibroblast; OCR,
oxygen consumption rate; OXPHOS, oxidative phosphorylation; PS, presenilin;
ROS, reactive oxygen species; SAD, sporadic AD; TEM, transmission electron
microscopy; TMRM, tetramethylrhodamine methyl ester; WB, western blotting.
endosomal compartments (Meckler and Checler, 2016; Sannerud
et al., 2016), they are both enriched in the mitochondria-
associated membranes (MAM) (Area-Gomez et al., 2009).
MAM are specific membrane domains connecting endoplasmic
reticulum (ER) and mitochondria. They are involved in lipid
metabolism, calcium and cholesterol homeostasis (vanVliet et al.,
2014; Filadi et al., 2017). PS2 has been reported to regulate the
formation of ER/mitochondria contacts (Filadi et al., 2016) and
calcium cross-talk between these two organelles (Zampese et al.,
2011a). It is hence of particular interest to define (i) the precise
contribution of PSs to the multiple aspects of mitochondrial
function and (ii) to understand the respective contribution of
PS1 or PS2 to these processes. Unraveling the role of PSs in
cell metabolism is crucial to get insight in their physiological
function and to understand how PS gain- or loss-of-function
can create a pathological context, related for instance to AD.
We performed an array of metabolic measurements on Mouse
Embryonic Fibroblasts cell lines (MEFs) derived either from wild
type (PS+/+), PS1/2 double knock-out (PSdKO), PS2KO, and
PS1KOmice embryos. We found a key role for PS2 (and not PS1)
in cell metabolism and especially in OXPHOS and glycolysis.
Indeed, the absence of PS2 altered the OXPHOS capacity and
integrity but increased glycolytic flux to support energy needs.
These pathways are crucial for energy-intensive consumer cells,
like brain cells. Such defects might set the basis for further
investigation of the metabolic impairments observed in AD.
MATERIALS AND METHODS
Cell Lines and Cell Culture
Mouse Embryonic Fibroblasts cell lines (MEFs) derived from
wild type (PS+/+), PS1/2 double knock-out (PSdKO), PS2KO
and PS1KO mice embryos were previously described (Hebert
et al., 2006; Marinangeli et al., 2015). Rescued cell lines refer
here to MEFs stably re-expressing human PS1 or PS2 in the
corresponding single KO background: PS2KO rescued by human
PS2 (2R2) and PS1KO rescued by human PS1 (1R1). Cells were
maintained in DMEM low glucose (5.5mM) (Sigma-Aldrich, St
Louis, USA) supplemented with penicillin/streptomycin solution
(10 units–10 µg) and 10% fetal bovine serum (FBS) (Thermo
Scientific, Rockford, USA). MEF 1R1 and 2R2 cell lines were
generated by subcloning the human PSs cDNA sequences
in the lentiviral backbone vectors plentiCMV/TOpuro and
pTMtm898neo, respectively. Lentiviruses were produced in
human embryonic kidney 293T cells. Supernatants containing
the lentiviruses were concentrated with the Lenti-X Concentrator
kit according to the manufacturer’s instructions (Clontech
Laboratories; California, USA). MEFs PS1KO and PS2KO
were transduced by lentiviral particles followed by puromycin
(2.5µg/ml) selection (1R1) and G418 (500µg/ml) selection
(2R2), respectively. Stable expression of human PSs was
monitored by western blotting (WB).
Western Blotting
WBwas performed on cell lysates as previously described (Stanga
et al., 2016). Primary antibodies used were Anti-OXPHOS
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Cocktail (1:1,000; Abcam, Cambridge, United Kingdom); Anti-
TOM20 (1:1,000; Proteintech, Rosemont, USA); anti-Presenilin
(1:1,000; Cell Signaling, Danvers, USA); anti-Actin (1:3,000;
Abcam, Cambridge, United Kingdom). Secondary antibodies
used were anti-mouse (1:10,000; GE Healthcare, Little Chalfont,
United Kingdom) and anti-rabbit (1:10,000; GEHealthcare, Little
Chalfont, United Kingdom).
Metabolic Measurements
Oxygen consumption rate (OCR)measurements were performed
with a Seahorse XF96 bioenergetic analyzer (Seahorse Bioscience;
Massachusetts, USA). Cells were plated at 80% cell confluence
onto a Seahorse 96 well plates 24 h before the assay. According
to manufacturer’s instructions, cell medium was replaced by the
conditional medium (culture medium without FBS and sodium
bicarbonate) and incubated at 37◦C without CO2 for 1 h before
completion of probe cartridge calibration. Inhibitors targeting
the different mitochondrial complexes (Cell Mito Stress Test
kit, Seahorse Bioscience) have been added sequentially to the
cells during the experiment to measure the basal respiration, the
coupling and the spare respiratory capacity: Oligomycin (1µM);
FCCP (1µM); Rotenone and antimycin A (0.5µM). Results were
normalized to the total amount of protein measured by the
Bradford assay kit (Bio-Rad Laboratories, California, USA).
Mitochondrial Membrane Potential (1ψ)
Fluorescent cationic probe tetramethylrhodamine methyl
ester (TMRM) (Sigma-Aldrich, St Louis, USA) was used to
evaluate the 19 . The uncoupling agent Carbonyl cyanide-4-
(trifluoromethoxy) phenylhydrazone (FCCP) served as control
(Sigma-Aldrich, St Louis, USA). Cyclosporin H (2µM; Abcam,
Cambridge, United Kingdom), an inhibitor of multidrug
resistance pump activity was used to limit the efflux of TMRM.
MEFs were incubated for 30min at 37◦C with TMRM (30 nM),
cyclosporine H with or without FCCP (10µM) diluted in KREBS
medium. For the flow cytometry (FC) analysis we trypsinized
cells seeded in 6 well plates and harvested them in PBS/5% FBS.
After centrifugation at 300 g for 5min, cells were resuspended
in KREBS medium for the FC analysis performed on a BD
FACSCantoTM flow cytometer (Biosciences; San Jose, USA). Data
were analyzed with the FlowJo software (FlowJo,LLC; Oregon,
USA).
Adenine Nucleotides Analysis
24 h after seeding in 10 cm culture dishes, cells were harvested
and lysed for 30min on ice with HCLO4 1N (Sigma-Aldrich,
St Louis, USA) and then centrifuged for 20min at 10,000 g at
4◦C. The pellets were re-suspended in NaOH 0.5M for protein
quantification and the supernatants were adjusted to pH 6–8
using a solution of KOH/KHCO3 3M (Sigma-Aldrich, St Louis,
USA). Precipitated salts were separated from the liquid phase by
centrifugation at 10,000 g at 4◦C for 20min. Samples were stored
at −80◦C. Nucleotides were separated by high-performance
liquid chromatography (HPLC) on 125 × 4.6-mm PartiSphere
5 SAX anion-exchange column (Whatman, Maidstone, UK).
Nucleotides were separated with a gradient from 100% buffer
A (0.01M NH4H2PO4, pH 3.7) to 100% buffer B (0.48M
NH4H2PO4, pH 3.7) over 27min at a flow rate of 2ml/min
according to the method of Hartwick and Brown (1975). UV
detection of nucleotides was performed at 254 nm.Quantification
of nucleotides was achieved by peak integration of the area under
the curve, validated by the use of external standards (ADP and
ATP).
NAD+/NADH Ratio
Cells were seeded in 96 well plates at 80% confluence 24 h
before the assay. NAD+/NADH ratio was measured by using
the bioluminescent NAD+/NADH-GloTM assay kit (Promega,
Wisconsin, USA) according to the manufacturer’s instructions.
Briefly, total NAD+ and NADH were extracted from cell pellets
with the basic solution 1% dodecyltrimethylammonium bromide
(DTAB). Samples were divided in two for both acid and basic
treatments and heated at 60◦C for 15min. The oxidized form is
selectively decomposed in the basic solution while the reduced
form is decomposed in the acidic solution. For the luminescent
reaction, samples were mixed with 100 µl of NAD+/NADH-
GloTM detection reagent and incubated for 45min before
reading on the GloMax R© 96-well plate luminometer (Promega,
Wisconsin, USA).
Glucose and Lactate Measurements
Cells were seeded at 80% confluence in 6 well plates. 24 h after,
500 µl of medium per well was collected and deproteinized.
Glucose and lactate concentrations were measured using specific
enzymatic assays on a CMA600 microdialysis analyzer (CMA
Microdialysis AB, Solna, Sweden). Cells were collected for
protein quantification and data were normalized to the amount
of protein measured by BCA assay (Thermo Scientific, Rockford,
USA).
Glycolytic Flux Measurement
Glycolytic rate was evaluated by measurement of the detritiation
rate of [3-3H] glucose. Briefly, tritiated glucose (0.2 µCi/ml;
Perkin-Elmer; Massachussets, USA) was added to the medium
(including 5.5mM glucose) for 30min. After medium removal,
the tritiated water resulting from detritiated glucose was
separated from the non-transported tritiated glucose by column
chromatography and measured with the Tri Carb 2,810 liquid
scintillation analyzer (Perkin Elmer; Massachussets, USA) as
described previously (Marsin et al., 2002). Data were normalized
to the amount of protein measured by BCA assay (Thermo
Scientific, Rockford, USA).
Complex I (CI) Enzyme Activity Assay
The activity of complex I of the mitochondrial respiratory chain
was evaluated with the Complex I Enzyme Activity Dipstick
Assay kit (Abcam, Cambridge, United Kingdom). Cells were
scraped in PBS and centrifuged for 5min at 4◦C at 500 g. 10
volumes of extraction buffer were added to the pellets prior to
20min of incubation on ice. After centrifugation, pellets were
discarded and supernatants were used to determine protein
concentration (BCA assay). Samples (corresponding to 30 µg
of proteins) were added to a microplate with blocking buffer.
The dipsticks (containing an antibody capturing the CI) were
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immersed in the samples to capture the CI. The NADH and NBT
were added to allow the oxidation of NADH by the complex
I, which in turn reduce NBT to form a purple precipitate.
Colorimetric signals were quantified with the Gel Doc 2,000
coupled with Quantity One software (Bio-Rad; California, USA).
Transmission Electron Microscopy (TEM)
Cells were fixed with 2.5% glutaraldehyde in phosphate buffer
and kept in the fixative during 1 h at room temperature. They
were washed and postfixed with 1% osmium tetroxide in the
same buffer containing 0.8% potassium ferricyanide at 4◦C. The
samples were dehydrated in acetone, infiltrated with Epon resin
during 2 days, embedded in the same resin and polymerised at
60◦C during 48 h. Ultrathin sections were obtained using a Leica
Ultracut UC6 ultramicrotome (Leica Microsystems, Vienna) and
mounted on Formvar-coated copper grids. They were stained
with 2% uranyl acetate in water and lead citrate. Sections were
observed in a Tecnai Spirit electron microscope equipped with
an Eagle CCD camera (FEI, Eindhoven, The Netherlands).
Statistical Analysis
The number of experiments for each experimental condition
is indicated in the figure legends. Data were analyzed using
GraphPad Prism software (GraphPad Software, La Jolla, CA,
USA) by ANOVA followed by Bonferroni’s multiple comparison
tests. ∗p< 0.05, ∗∗p< 0.01, ∗∗∗p< 0.001.
RESULTS
Absence of PS2 Results in Decreased
OXPHOS without Alteration of the 19
PSs expression profile was measured by WB in MEF cell
lines with antibodies directed against PS1 and PS2 CTFs
(Figures 1A,B). The expression profile indicated the restoration
of PSs expression in 2R2 (PS2 KO stably expressing human
PS2) and 1R1 (PS1KO stably expressing human PS1). We
evaluated the OXPHOS capacity by measurement of the OCR.
The overall profile of OCR and the parameters related to the
OXPHOS activity measured before or after drug addition, that
are basal respiration, coupling (oxygen consumption devoted to
ATP synthesis under resting conditions) and spare respiratory
capacity (maximal uncoupled rate of respiration minus the
basal rate) were all impaired in PSdKO and PS2KO cells
(Figures 1C–F). Stable re-expression of PS2 in the PS2KO
background (2R2) restored all these parameters to the levels
measured in control cells (PS+/+). Importantly, the absence of
PS1 did not affect mitochondrial respiration. We next measured
the ∆9 with the TMRM probe by FC (Figure 2A) and by
fluorescence measurement in microplates (Figure S1A). FC
analyzes were performed on gated homogenous populations
that accounted for more than 90% of the total population
(Figure S1B). FCCP, an uncoupling agent abolishing 19
was used as a control. In both approaches (FC and direct
fluorescence measurements), no significant differences in 19
were observed between the different populations of MEFs,
although oxygen consumption was altered in PS2KO and PSdKO
cells.
Increased Anaerobic Glycolysis Sustains
the Energy Production in PSdKO and
PS2KO MEFs
The observed PS2-dependent OXPHOS capacity decrease
without impairment of 19 led us to evaluate the total ADP
and ATP cellular levels. This was achieved by HPLC. No
differences were observed in the ADP/ATP ratio between
the cell lines (Figure 2B). Considering that we detected a
significant decrease in coupling in PSdKO and PS2KO cells,
we suspected that ATP production in PSdKO and PS2KO
cells could result from an increased glycolysis (Figures 2C,D)
that would counteract the defects observed in OXPHOS. We
measured the levels of lactate secreted and glucose consumed
by cells, as marker of glycolysis (Figure 2C). Both were indeed
significantly higher in PSdKO and PS2KO cells. No changes were
observed in PS1KO cells. Lactate secreted and glucose consumed
measured in 2R2 cells were comparable to those measured
in PS+/+ cells. These data were in line with the significant
increase of the glycolytic flux (measured by detritiation of [3-
3H] glucose) observed in PSdKO and PS2KO cells, that was
also restored in 2R2 to the levels measured in PS+/+ cells
(Figure 2D).
Absence of PS2 Impairs the ETC
So far, our results showed that mitochondrial oxidative capacity
was impaired in the absence of PS2. This defect can be
compensated by the increased glycolytic flux we observed.
We further investigated the mitochondrial defects by profiling
the expression of the five mitochondrial complexes. This was
performed by WB with a cocktail of antibodies targeting
representative subunits of the five mitochondrial complexes.
Results showed that the expression of some complexes of
the ETC was perturbed in PSdKO and PS2KO cells: CI and
CII subunits were significantly decreased in both cell lines,
and CIV was more specifically decreased in PS2KO cells. The
expression profile of CI, CII, and CIV was restored in 2R2 cells
(Figures 3A,B). To confirm these observations, we measured
by an enzymatic assay the activity of the CI, which was
significantly decreased in PSdKO and PS2KO cells but totally
restored in 2R2 cells (Figure 3C). Since CI uses NADH as an
electron donor, we assessed whether the redox state was also
affected by measuring the NAD+/NADH ratio. We measured the
NAD+/NADH ratio using a luminescence assay. Consistent with
the measurement of CI subunits byWB, NAD+/NADH ratio was
decreased in PSdKO and PS2KO cells and restored in 2R2 cells
(Figure 3D).
Mitochondrial Morphology in PSs-Deficient
Cells
We measured by WB in cell lysates the expression level of the
mitochondrial import receptor subunit TOM20 (Figures 4A,B)
as a marker of mitochondrial mass (Whitaker-Menezes
et al., 2011). No significant difference in TOM20 levels
was observed between the different cell types suggesting a
comparable mass of mitochondria in all the cell lines tested,
including PSdKO and PS2KO cells. Mitochondrial mass is
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FIGURE 1 | Assessment of the OXPHOS capacity by measurement of the OCR. Experiments were carried out in MEF cell lines wild type (PS+/+), PS1/2 double KO
(PSdKO), PS2KO, PS1KO and rescued cell expressing human PS1 and PS2 in PS1KO and PS2KO backgrounds, respectively (2R2 and 1R1). PSs expression (A,B)
was analyzed by WB in cell lysates. Actin was used as a loading control. (C). OCR was determined using the Seahorse XF96 bioenergetic analyzer. Vertical lines
indicate the time point at which the different compounds have been added: a. Oligomycin (CV inhibitor) b. FCCP (19 uncoupler) c. Rotenone (CI inhibitor) and
antimycin A (CIII inhibitor). The basal respiration (D), the coupling ratio (E) and the spare respiratory capacity (F) were calculated according to the Cell Mito Stress Test
kit’s recommended protocol. Values (means ± sem) are given in pmol O2/min/µg protein.*p < 0.05, **p < 0.01, ***p < 0.001 (n = 18 from 3 independent
experiments).
a gross indicator that could be only hardly related to the
changes in mitochondrial function we observed. Thus, general
mitochondrial morphology was evaluated by immunofluorescent
staining targeting TOM20 (Figure S2), and no significant
changes were observed about the shape and distribution of the
mitochondrial network. Morphology and structure of single
mitochondria were evaluated by TEM. Strikingly, we observed
defective cristae (Figure 4C) in PSdKO and PS2KO cells when
compared to PS+/+ cells. Cristae were less defined and less
numerous in MEFs PSdKO and PS2KO and, importantly,
these morphological defects were not observed in PS1KO
cells.
DISCUSSION
The physiological function of the Presenilins 1 and 2 is far
from being fully elucidated. Over the two last decades, the
seminal observation identifying PS1 as the catalytic core of the
γ-secretase (De Strooper et al., 1998; Kimberly et al., 2003)
launched a considerable research effort aimed at understanding
the exact role of PSs in γ-secretase activity and Aβ production.
However, an increasing number of studies focused on γ-secretase
independent PSs functions such as regulation of calcium
homeostasis (Zhang et al., 2013) or neurotransmitter (glutamate)
release (Zhang et al., 2009). Since PSs were shown to be enriched
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FIGURE 2 | Evaluation of the 19, ADP/ATP ratio and glycolysis. 19 was evaluated in MEF cells with the TMRM probe in the presence or absence of the 19
uncoupling agent FCCP and analyzed by FC (n = 4 from 2 independent experiments) (A). Histogram peaks represent (from left): autofluorescence; relative
fluorescence of cells treated with TMRM+FCCP and of cells treated with TMRM only. The merge of histograms (in green) plots the overlapping signal obtained for the
4 cell lines in the TMRM only condition. Signals obtained were quantified (bottom) and results are expressed as the percentage of relative mean fluorescence intensity
measured in PS+/+ cells. (B). ADP and ATP were measured by HPLC 24h after seeding and data, expressed as ADP/ATP ratio, were normalized to protein content
(n = 6 from 3 independent experiments). (C). Glucose consumption (negative columns) and lactate release (positive columns) were measured in supernatant from
fresh medium after 24 h of culture. Data were normalized to protein content and expressed as µmol/day/µg prot. *p < 0.05, **p < 0.01, (n = 16 from 6 independent
experiments). (D). Glycolysis rate was determined by the detritation rate of [3-3H] glucose after a 30min incubation. Data were normalized to protein content. *p <
0.05, **p < 0.01, ***p < 0.001 (n = 12 from 6 independent experiments).
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FIGURE 3 | Mitochondrial respiratory chain complexes expression profile, NAD+/NADH ratio and CI activity. (A). The expression level of representative protein
subunits from each of the five mitochondrial complexes (NDUFB8 for CI; SDHB for CII; UQCRC2 for CIII; MTCO1 for CIV; ATP5A for CV) was analyzed by WB on cell
lysates. Actin was used as a loading control (n = 5 from 5 independent experiments). (B). WB quantifications (means ± sem) are given as percentage of signal
measured in PS+/+ cells.*p < 0.05, ***p < 0.001. (C). Mitochondrial CI activity was evaluated by the enzyme activity dipstick assay. **p < 0.01, ***p < 0.001 (n = 12
from 6 independent experiments). (D). NAD+/NADH ratio was quantified by a bioluminescent kit *p < 0.05, **p < 0.01 (n = 24 from 8 independent experiments).
Frontiers in Physiology | www.frontiersin.org 7 October 2017 | Volume 8 | Article 796
Contino et al. Presenilin 2 in Mitochondrial OXPHOS
FIGURE 4 | Characterization of mitochondrial mass and morphology. TOM20 expression was analyzed by WB on cell lysates (A). Tubulin was used as a loading
control. TOM20 quantification (B) (means ± sem) is given as the percentage of the signal measured in the PS+/+ cells (n = 6 independent experiments). (C) TEM’s of
cell section. Higher magnification regions (right columns) are boxed in white (left column). Red stars are indicating the position of the mitochondria on the micrograph.
Scale bars are indicated on the bottom of the pictures.
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in MAM, a domain involved in different pathways related to ER
and mitochondria functions (van Vliet et al., 2014; Filadi et al.,
2017), we investigated the potential role of PSs in the control
of cellular metabolism by measuring an array of parameters
related to mitochondrial activity in PSs-deficient MEF cell lines.
We observed in the absence of PS2, alterations in OXPHOS
capacity and integrity associated with a decrease NAD+/NADH
ratio. Along with these functional defects, the integrity of the
mitochondrial cristae was also affected. These defects occurring
in absence of PS2 were compensated by an increased glycolysis.
Mitochondrial function was fully restored by stable re-expression
of PS2 in our model.
PS2 in OXPHOS and 19
We measured the OCR as an indirect measurement of the
OXPHOS. Our results indicate a significant decrease in PSdKO
and PS2KO of the OCR. All the parameters we measured
(basal respiration, coupling and spare respiratory capacity) were
decreased in PSdKO and PS2KO cells, supporting a general
defective OXPHOS capacity. One could have expected here an
impact on the 19 and ATP production, since the ATP synthase
uses the electrochemical gradient formed by pumping protons
through the inner membrane to produce ATP. With the TMRM
probe, we observed that the 19 measured is stable in all the cell
types. Previous studies reported a 19 decrease in PSdKO and
PS2 KO cells (Behbahani et al., 2006). This discrepancy could be
due to different procedures as for instance the use of a different
probe (JC-1) at high concentration (Perry et al., 2011). Behbahani
et al. used like us FC analysis as a readout for 19 , but it should
be noted that in their case the use of the JC-1 probe to measure
19 changes implies a shift in the emission wavelength of the
probe (with overlapping spectra) that renders the analysis by
FC more difficult to interpret. With the TMRM probe, by using
FC or direct fluorescent measurement in microplates (see Figure
S1) as a readout we observed that the 19 is stable in all the
cell types analyzed. 19 is also known to be one of the most
stable parameter in the cell; even in the case of a deficit, the ATP
synthase will work in reverse to keep it stable (Uechi et al., 2006).
To note, the main source of ROS production is the ETC,
and their implication in AD could rise the question about their
production in our model. We could expect a decrease of ROS
production in PSdKO and PS2KO regarding of the OXPHOS
deficit. A previous study showed a ROS increase in PSdKO
compared to PS+/+, in serum deprivation conditions (Boo et al.,
2009) that we do not modelize here. We performed few pilot ROS
measurement (data not shown) in basal state but no significant
message came up. It would be of interest, given the implication
of ROS in AD, to further study the PSs-dependent and ROS
production in relevant models.
PS2 and ATP Production
Surprisingly, the ADP/ATP ratio we measured by HPLC was
not impaired while the coupling (oxygen dedicated to ATP
production) was significantly decreased in PSdKO and PS2KO
cells. This is consistent with the increase of glycolytic flux and
lactate production we observed in PSdKO and PS2KO cells.
We used two distinct approaches to estimate glycolysis in our
model: (i) we measured the levels of glucose consumed and
lactate released in cell media; (ii) we measured the glycolysis
rate by detritiation of [3-3H]glucose. These combined approaches
showed that the glycolysis is increased significantly in PSdKO and
PS2KO, providing the fuel to compensate their OXPHOS deficit.
It should be noted that, similarly to undifferentiated stem cells (de
Meester et al., 2014), MEF cell lines use anaerobic glycolysis even
in the presence of oxygen to produce their energy. It would be of
prime interest to analyze if such compensatory capacity exists in
non-proliferative and oxidative cells like primary neurons. The
metabolic phenotype resulting from altered PS2 function could
be more drastic in neuronal cells. This would be very important
in the context of the Alzheimer pathology, in which PSs play a
central role. Zampese and collaborators highlighted in SH-SY5Y
neuronal cells overexpressing a FAD PS2 mutant an enhanced
Ca2+ transfer between ER and mitochondria (Zampese et al.,
2011b). On the other hand, SH-SY5Y treated with siRNA specific
for PS2 showed a decreased contact between mitochondria and
ER, which induced a decrease in calcium flux. The calcium
crosstalk is known to be an important messenger for Krebs
cycle enzymes stimulation and kinetics of the mitochondrial
complexes. The mitochondrial calcium sequestration capacity is
also important in the excitotoxicity and mitochondrial oxidative
stress related to AD. It is therefore possible that a lack of calcium
flux could be one cause of the OXPHOS defect observed in our
PS2KO cells.
PS2 in ETC and Mitochondrial Network and
Morphology
We found that the bioenergetics defects observed were neither
due to a decrease in the mitochondrial mass nor associated with a
compensatory induction in mitochondrial mass. This favors the
hypothesis of a direct disruption of the ETC activity in absence
of PS2 rather than an overall defect in mitochondria biogenesis.
This would be interesting to further address in postmitotic cells,
such as neurons, where one might expect a proliferation of
mitochondria as an attempt to compensate for the OXPHOS
deficits. Such a compensatory induction was seen in heart and
muscle (and to a lesser extent in brain) of mice deficient in the
adenine nucleotide translocator-1 (ANT1), on which OXPHOS
depends since it provides the ADP substrate (Esposito et al., 1999)
In order to understand the origin of the OXPHOS defect, we
assessed the expression profile of the 5 mitochondrial complexes
(CI-CV) of the ETC with a cocktail of antibodies. Even if we
did not evaluate the expression of the entire complexes by this
approach, we found the expression of several complexes of the
ETC (CI, CII, and CIV) to be decreased in PSdKO and PS2KO
cells. This was consistent with a functional analysis indicating
a decreased CI activity in the same cells. The most important
electron donor produced by the Krebs cycle and used by the
CI is NADH and NAD+ is an important co-factor regulating
metabolic homeostasis (Canto et al., 2015).We therefore assessed
their redox state by measuring the NAD+/NADH ratio and
observed a significant decrease of the ratio in PSdKO and PS2KO
cells. This can result either from an accumulation of NADH
not used by the dysfunctional CI or from a decrease in NAD+
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associated to metabolic pathways. NAD+ and NADH could also
both be affected and synergistically influence pathways regulating
metabolism homeostasis (Canto et al., 2015).
The perturbation of the integrity of the ETC in PSdKO
and PS2KO correlates with an altered structure of their
cristae as evidenced by TEM. Cristae are the seat of the
ETC, it is thus logical that the OXPHOS capacity and
complexes expression are affected when their structure is
altered. It has been demonstrated that cristae shape could
regulate respiratory chain supercomplexes assembly and stability,
impacting the respiratory efficiency (Cogliati et al., 2013).
One of the key regulators of cristae shape is OPA1 and
it would be interesting to further study the relationship
between PS2 and OPA1. Alternatively, considering MAM as
an important compartment for the homeostasis of lipids such
as for example cardiolipin, one of the most prominent lipids
in cristae (Paradies et al., 2014; Ikon and Ryan, 2017), we
suggest that the morphological deficit of the cristae could
be related to a dysregulation of MAM function in absence
of PS2. To note, the MAM hypothesis has been proposed
in AD since all the pathways (cholesterol, lipid and calcium
homeostasis, mitochondrial OXPHOS stimulation) controlled by
this compartment are altered in the pathology (Area-Gomez and
Schon, 2017).
In conclusion, we reported here a specific physiological role
of PS2 in cellular metabolism. Indeed, absence of PS2 results
in defective mitochondrial cristae correlating with an impaired
OXPHOS capacity and a modified redox state (NAD+/NADH
ratio). MEF cell lines, which are glycolytic cells, increase this
glycolytic capacity to sustain their energy need in absence of PS2.
This implies that impairment of these PS2-dependent processes
could be involved in the progression of pathologies like AD in
which PS2 play a key role. Investigation in an oxidative model
and particularly in neurons are required to further explore this
hypothesis.
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